Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06030752 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

WMT for Autism Spectrum Disorder (ASD)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Phase changed: Phase 1 → not specified Show 4 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 6 of 6 entries
    • Site details revised at 1 of 2 sites
    • Publications: details revised at 12 of 12 entries
  2. Notable Enrollment target: 30 to 80v5 Show 4 more changesShow less
    • Primary completion date: Apr 4, 2026 to Apr 4, 2027
    • Study completion date: May 1, 2026 to May 1, 2027
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints revised (6)
  3. Minor Secondary endpoints: 4 to 6
    • Eligibility criteria expanded, about 1 word
    v4
  4. Minor Eligibility criteria shortened, about 34 words
    • Secondary endpoints: 2 to 4
    v3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jan 1, 2024 to Apr 4, 2026
    • Study completion date: Apr 1, 2024 to May 1, 2026
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Autism Spectrum Disorder (ASD) is a group of serious neurodevelopmental disorders. A significant comorbidity exists between ADHD and ASD: 30%-50% of individuals with ASD exhibit ADHD symptoms, and two-thirds with ADHD show ASD traits. Intestinal microbial disturbance is common in children with ASD. A great deal of evidence shows that intestinal microbes can influence the brain to play its role through "gut-brain-microbiota axis". We intend to explore the role of Washed Microbiota Transplantation in improving symptoms of children in ASD with or without ADHD; To study the potential etiological mechanism of WMT for the neurodevelopmental disorders.
Trial Details
NCT Number NCT06030752
Lead Sponsor The Second Hospital of Nanjing Medical University
Collaborators: Nanjing Medical University
Conditions
(from sponsor)
Autism Spectrum Disorder
Related terms Autism Spectrum Disorder
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov